Yong-zhi Lu

Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors

Guang-Biao Zhou, S. Tao, Xin Cheng, 2015, Oncotarget.

Skp 1 in lung cancer : clinical significance and therapeutic efficacy of its small molecule inhibitors

Guang-Biao Zhou, S. Tao, Gui-zhen Wang, 2015 .

Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.

Guang-Biao Zhou, Min Wang, Kuojun Zhang, 2020, International journal of oncology.

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor

Guang-Biao Zhou, S. Tao, Bo Zhou, 2016, Oncotarget.

Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer.

Shanshan Wang, Shuyan Liu, Qiong Li, 2019, The international journal of biochemistry & cell biology.

Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists

Yan Zhang, Xiao-yu Luo, Yong Xu, 2016, Acta Pharmacologica Sinica.

Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors.

Guang-Biao Zhou, S. Tao, Xin Cheng, 2015, Oncotarget.